Dr. Nevena Lucic, MD

Dr. Lucic practices at NewYork-Presbyterian/Weill Cornell Medical Center in New York, New York, part of NewYork-Presbyterian Hospital.

Dr. Lucic's NPI, 1841500154, was assigned on October 20, 2010. Dr. Lucic holds New York license 259156.

Dr. Lucic's primary practice is NewYork-Presbyterian/Weill Cornell Medical Center, at 525 East 68th Street, New York, NY 10065 in New York County. The practice phone is (212) 746-5454.

Dr. Lucic's primary practice is NewYork-Presbyterian/Weill Cornell Medical Center in New York, New York, part of NewYork-Presbyterian Hospital. The medical group on file is Weill Cornell Physicians. Dmand AI also links Dr. Lucic to 2 more clinical labs and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Lucic practices, 4 sites in all. Vendor and product names are available with a free account.

Hematology and oncology is Dr. Lucic's primary specialty in the NPI Registry, under taxonomy code 207RH0003X. Dr. Lucic is licensed in New York.

CMS data shows 631 Medicare services from Dr. Lucic across 3 procedure codes in 2024, for 174 Medicare patients. Medicare paid $67,822 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 174 Medicare patients who saw Dr. Lucic in 2024. The largest group is 75 to 84, with 86 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 20% are also on Medicaid. Their average risk score is 3.77, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Lucic's median patient age at 65, with 54% women.

In 2019, Dr. Lucic wrote 13 Medicare Part D claims. They cover 1 drug, with $6,042 in total drug cost. In 2018, CMS named 46 claims across 3 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 100 out of 100 for Dr. Lucic for performance year 2024, reported through an alternative payment model (APM). Dr. Lucic accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

CMS Open Payments shows 5 general payments to Dr. Lucic from 3 drug and device companies from 2018 to 2025. Food and beverage make up the largest share, 93% of the total. Rigel Pharmaceuticals, Inc. paid the most, $414.